Kochi, Kerala, February 13, 2017 /India PRwire/ — In a first in the state, doctors at VPS Lakeshore successfully performed 3D ArmorCoat System total knee replacement surgery on a 66-year-old patient, Radhamani Bhaskaran, a native of Chengannur in Alappuzha.

The surgery was performed by a medical team under Dr. Jacob Varghese and Dr. Bibin Theruvil. According to the doctors, 3D Knee ArmorCoat system increases the stability and comfort level and enables patients to walk and climb without any difficulty.

“The conventionally replaced knee normally last only for 15-18 years. It necessitates complicated, costly and risky revision surgeries in the patients who have undergone knee replacement surgeries at a younger age. ArmorCoat with Vitamin-E poly has been specially designed after taking this factor in consideration,” said Dr. Jacob Varghese.

The ArmorCoat 3D Knee is rated with Gold Standard, a rating created for 3D Knee, popularly known as GOLD ON GOLD Knee, a knee replacement system designed to improve strength, stability, and flexion in patients. According to the doctors, 3D Knee produced 57 per cent less wear in lab tests compared to the premium performing Direct Molded insert components.

Explaining on the knee surgeries, Dr. Bipin Theruvil said that the insert acts a substitute for the cartilage and meniscus, which was worn away due to arthritis. “The femur moves on top of the inserted component and supports the weight of the body. The insert, therefore, can be prone to wear, particularly in a more active person. The wear can happen due to impact on the insert as well as degradation due to exposure to oxygen. The primary cause of revision surgery is wear, which can be reduced by Vitamin-E poly,” he said.

The E-plus total knee replacement insert component was developed by the US-based DJO Surgical. “E-plus was the first total knee replacement material to be offered to patients in the U.S. with vitamin E blended into the insert component in July 2001,” said Dr. Paul D. Maitino, Joint Replacement Specialist, Surgical Hospital of Oklahoma, USA and one of the designers of the knee.

The medical team added that this knee provide the best in class knee replacement solution in high demanding and active lifestyle. “The Gold Standard knee has among the lowest simulated wear rates for a total knee replacement in the U.S. I am very excited to offer our patients the highest level of technology available to maximise benefits in longevity and performance when it comes to knee replacement surgery,” added Dr. Jacob Varghese.

Notes to Editor

VPS Lakeshore, one of the largest, most comprehensive, independent multi-specialty hospitals in Kerala is recognized as a leader in medical education, groundbreaking research, and innovative,patient-centered clinical care. The hospital has become the hospital of choice to patients’ worldwide providing emergency, primary, and specialty care in virtually every field of medicine.

The advanced hi-tech healthcare facility ushers in world class standards in healthcare and offers diverse medical specialties, including Multi Organ Transplantation, Gastroenterology, G.I Surgery, Medical, Surgical Oncology, Joint Replacement, Accident & Trauma Orthopedics, Sports Medicine, Neurology, Neurosurgery Surgery, Cardiology, Cardiovascular Surgery, Gynecology & more…

VPS Lakeshore was incorporated as a public limited company in 1996 and in January 2003 the hospital officially opened its doors to integrated healthcare. Over the years, the hospital has emerged as a centre of international healthcare excellence for patients in India & abroad through a broad range of advanced clinical programs and the most cutting-edge treatments and diagnostic services.

EL DORADO HILLS, CA (PRWEB) FEBRUARY 14, 2017

Consensus Orthopedics, a global total joint orthopedics leader, announced today the promotion of Curt Wiedenhoefer to President of Consensus Orthopedics. Mr. Wiedenhoefer previously served as COI’s Executive Vice President of Global Sales & Marketing. He brings over two decades of experience in orthopedics and is widely respected in the industry. Mr. Wiedenhoefer, who has an extensive background in medical electronic devices, has been instrumental in heading a new product line that will be launching at AAOS in San Diego this March.

“Curt combines deep knowledge of our company and capabilities with strong relationships in this market,” said Chief Executive Officer Colleen Gray. “He leads a solid team that is helping drive our orthopedic business to record sales.”

Curt Wiedenhoefer said “I am extremely grateful for the trust our CEO, Colleen Gray, and our Board of Directors, is placing in me to assume this new position, and I am privileged to help lead the exceptionally talented men and women of Consensus. I look forward to continuing to build upon Consensus Orthopedics’ unique ‘family’ culture and the value proposition we provide to all of our customers around the world.”

About Consensus Orthopedics, Inc.
With over 20 years of orthopedic design and manufacturing experience, Consensus Orthopedics is committed to providing proven and reliable total joint implants and instruments to the global market. Located in Northern California, Consensus is a dynamic and high-quality USA manufacturer of hip and knee implants which have a solid reputation for performance and reliability. Together, through a focus on patient care and clinician relationships, we are dedicated to creating one team and providing exceptional outcomes. Learn more at http://www.consensusortho.com.

ROSEMONT, Ill., Feb. 10, 2017 /PRNewswire-USNewswire/ — Following the confirmation of Congressman Tom Price as the new Secretary of the United States Department of Health and Human Services (HHS), the American Association of Hip and Knee Surgeons (AAHKS) congratulates Dr. Price on being appointed to a position for which he is uniquely suited.

Dr. Price’s experience as a physician gives him a critically important perspective on the real-world impact of health policy including the importance of access, coverage, the doctor-patient relationship, clinical decision making and challenges of navigating a complex health care environment. “We have confidence that as a physician, he will seek to put patients first in his role as HHS Secretary,” said William A. Jiranek, AAHKS President.

Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, today  announces, in accordance with Listing Rule 9.6.11(2) R, that Brian Larcombe will retire as Senior Independent Director and Non-Executive Director at the conclusion of the Annual General Meeting on 6 April 2017.

Following the Annual General Meeting on 6 April 2017, and subject to his re-election as a Director of Smith & Nephew plc at the Annual General Meeting, Ian Barlow will be appointed as the Senior Independent Non-Executive Director, in place of Brian Larcombe.

On 1 March 2017, Ian Barlow will step down as Chairman of the Audit Committee and Robin Freestone will be appointed Chairman of the Audit Committee in his place.

Roberto Quarta, Chairman, said

“Brian Larcombe has served Smith & Nephew for many years, as our Senior Independent Director since 2014, and as a member of the Audit, Nomination & Governance and Remuneration Committees. We will miss his great wisdom and experience. On behalf of the whole Board I thank him for his service and wish him well for the future.”

Enquiries

About Smith & Nephew

Smith & Nephew is a global medical technology business dedicated to helping healthcare professionals improve people’s lives. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma & Extremities, Smith & Nephew has around 15,000 employees and a presence in more than 100 countries. Annual sales in 2015 were more than $4.6 billion. Smith & Nephew is a member of the FTSE100 (LSE:SN, NYSE:SNN).

For more information about Smith & Nephew, please visit our website www.smith-nephew.com, follow @SmithNephewplc on Twitter or visit SmithNephewplc on Facebook.com.

^{Forward-looking Statements}

^{This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as “aim”, “plan”, “intend”, “anticipate”, “well-placed”, “believe”, “estimate”, “expect”, “target”, “consider” and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew’s most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew’s expectations.}

^{◊  Trademark of Smith & Nephew.  Certain marks registered US Patent and Trademark Office.} 

Published: Wednesday, Jan. 25, 2017

The Northwestern Medicine Kishwaukee Hospital Joint Center has earned The Joint Commission’s Gold Seal of Approval for Advanced Certification for Total Hip and Total Knee Replacement.

The advanced certification is for Joint Commission-accredited hospitals, critical access hospitals and ambulatory surgery centers seeking to elevate the quality, consistency and safety of their services and patient care. Kishwaukee Hospital Joint Center is the first in the state of Illinois to receive this recognition.

“We are pleased to receive the advanced certification from The Joint Commission, the premier health care quality improvement and accrediting body in the nation,” Dave Smith, joint care coordinator at Kishwaukee Hospital, said in a news release. “We look forward to improving patient safety and quality of care for the increasing number of patients undergoing total hip or total knee replacement surgery.”

The center underwent a rigorous onsite review in November 2016. Joint Commission experts evaluated compliance with advanced disease-specific care standards and total hip and total knee replacement requirements, including orthopedic consultation, and pre-operative, intraoperative and post-surgical orthopedic surgeon follow-up care.

Established in 2016 and awarded for a two-year period, the advanced certification was developed in response to the growing number of patients undergoing a total hip or total knee replacement surgery, as well as the increased focus on clinical evidence-based patient care as it relates to pain management, quality of life issues, functional limitation in mobility and the return to normal daily activities.

The Kishwaukee Hospital Joint Center has changed the joint replacement experience by using research-based best practices, providing a Joint Center coordinator to guide the process of a joint replacement, advanced training, pre-operative educational training, a personal coach, and a group emphasis both pre- and post-operative. These practices have led to better outcomes. Patients experience a one-day hospital stay, discharged directly to their home rather than a nursing facility, and are up and walking more than 300 feet the morning after surgery with the ability to once again fully extend their knee.

UAE, Feb 6: US-based Stryker, a global orthopedic implants and medical equipment provider, visited Gulf Medical University (GMU) on February 4 to organize a workshop on advanced hip replacement surgery titled, ‘Hip Replacement: Primary and Revision Course’. More than 12 leading Middle Eastern surgeons participated in the workshop organized by leading international orthopedic surgeons, professor Michael Nogler from the Medical University of Innsbruck (Austria) and professor Mohammad Ghazavi from the Scarborough Hospital (Toronto, Canada).